Company Overview of Sinapis Pharma, Inc.
Sinapis Pharma, Inc. operates as a clinical stage biotechnology company that develops Methamphetamine, an intravenous neuroprotective agent for treating stroke, traumatic brain injury, and other ischemic and traumatic conditions in patients. The company was founded in 2009 and is based in Jacksonville, Florida.
4350 Pablo Professional Court
Jacksonville, FL 32224
Founded in 2009
Key Executives for Sinapis Pharma, Inc.
Similar Private Companies By Industry
|Medicinal Genomics Corporation||United States|
|Zor Pharmaceuticals LLC||United States|
|CDI Laboratories, Inc.||United States|
|Maxygen, Inc.||United States|
|DEKALB Genetics Corporation||United States|
Recent Private Companies Transactions
September 19, 2014
April 9, 2014
To contact Sinapis Pharma, Inc., please visit www.sinapispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.